These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19237223)

  • 1. Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.
    Marrero JA
    J Hepatol; 2009 Apr; 50(4):659-61. PubMed ID: 19237223
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.
    Roskams T; Kojiro M
    Semin Liver Dis; 2010 Feb; 30(1):17-25. PubMed ID: 20175030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.
    Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE
    Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Zou ZQ; Ding YP; Long B; Yuh JG; Xu AL; Lang ZW; Zou SY; Liu YD; Ding K; Li YY
    Hepatogastroenterology; 2010; 57(102-103):1285-90. PubMed ID: 21410073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamine synthetase, heat shock protein-70, and glypican-3 in intrahepatic cholangiocarcinoma and tumors metastatic to liver.
    Lagana SM; Moreira RK; Remotti HE; Bao F
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):254-7. PubMed ID: 22914614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genomic analysis of hepatocellular carcinoma and its application to diagnosis].
    Murakami Y
    Nihon Rinsho; 2010 Aug; 68 Suppl 8():458-61. PubMed ID: 20979296
    [No Abstract]   [Full Text] [Related]  

  • 7. Candidate molecular markers for histological diagnosis of early hepatocellular carcinoma.
    Sakamoto M; Mori T; Masugi Y; Effendi K; Rie I; Du W
    Intervirology; 2008; 51 Suppl 1():42-5. PubMed ID: 18544947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathology of hepatitis B virus-related hepatocellular carcinoma with a comparison to hepatitis C virus-related hepatocellular carcinoma].
    Kojiro M; Nakashima O; Takazawa T
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):713-7. PubMed ID: 12442472
    [No Abstract]   [Full Text] [Related]  

  • 9. Glypican-3: from the mutations of Simpson-Golabi-Behmel genetic syndrome to a tumor marker for hepatocellular carcinoma.
    Jakubovic BD; Jothy S
    Exp Mol Pathol; 2007 Apr; 82(2):184-9. PubMed ID: 17258707
    [No Abstract]   [Full Text] [Related]  

  • 10. [Variable clinical symptoms of hepatocellular carcinoma].
    Struve C; Heusermann U
    Dtsch Med Wochenschr; 1988 Feb; 113(8):294-6. PubMed ID: 2449323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma.
    Chuma M; Sakamoto M; Yamazaki K; Ohta T; Ohki M; Asaka M; Hirohashi S
    Hepatology; 2003 Jan; 37(1):198-207. PubMed ID: 12500205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy.
    Wang FH; Yip YC; Zhang M; Vong HT; Chan KI; Wai KC; Wen JM
    J Clin Pathol; 2010 Jul; 63(7):599-603. PubMed ID: 20501450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A2 as a differential diagnostic marker of hepatocellular tumors.
    Longerich T; Haller MT; Mogler C; Aulmann S; Lohmann V; Schirmacher P; Brand K
    Pathol Res Pract; 2011 Jan; 207(1):8-14. PubMed ID: 20971570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinicopathological features of hepatitis B- and C-related hepatocellular carcinoma.
    Shiratori Y
    J Gastroenterol Hepatol; 1996 Oct; 11(10):942-3. PubMed ID: 8912131
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect and clinical significance of methylation of 14-3-3 sigma gene in hepatitis B virus-related hepatocellular carcinoma].
    Gao YF; Su Q; Li JB; Wei SF; Li X
    Zhonghua Gan Zang Bing Za Zhi; 2010 Feb; 18(2):144-5. PubMed ID: 20196956
    [No Abstract]   [Full Text] [Related]  

  • 16. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.
    Di Tommaso L; Destro A; Seok JY; Balladore E; Terracciano L; Sangiovanni A; Iavarone M; Colombo M; Jang JJ; Yu E; Jin SY; Morenghi E; Park YN; Roncalli M
    J Hepatol; 2009 Apr; 50(4):746-54. PubMed ID: 19231003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma: the need for progress.
    Thomas MB; Zhu AX
    J Clin Oncol; 2005 May; 23(13):2892-9. PubMed ID: 15860847
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatocellular carcinoma: comparison of two different periods at the same center.
    Soresi M; La Spada E; Giannitrapani L; Campagna E; Di Gesaro V; Granà W; Sandonato L; Brancatelli G; Rotolo G; Affronti A; Messina S; Montalto G
    Eur J Intern Med; 2010 Apr; 21(2):127-30. PubMed ID: 20206885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Relationship of heat shock protein 70-2 gene polymorphism with hepatocellular carcinoma].
    Li WQ; Wang CD; Lin JA; Chen YL; Wu T; Liu X; Chen RQ
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jul; 18(7):538-9. PubMed ID: 20678448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.